Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/22824| Title: | Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren' | Authors: | Saad, E. D. BUYSE, Marc |
Issue Date: | 2016 | Publisher: | ELSEVIER | Source: | ANNALS OF ONCOLOGY, 27(8), p. 1653 | Abstract: | 6. Yoon SH, Kim KW, Goo JM, Kim DW, Hahn S. Observer variability in RECIST-based tumour burden measurements: a meta-analysis. Eur J Cancer 2016; 53: 5-15. 7. Marten K, Auer F, Schmidt S et al. Inadequacy of manual measurements compared to automated CT volumetry in assessment of treatment response of pulmonary metastases using RECIST criteria. Eur | Notes: | [Saad, E. D.; Buyse, M.] Int Drug Dev Inst, Louvain La Neuve, Belgium. [Saad, E. D.] Dendrix Res, Sao Paulo, Brazil. [Buyse, M.] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Diepenbeek, Belgium. | Document URI: | http://hdl.handle.net/1942/22824 | ISSN: | 0923-7534 | e-ISSN: | 1569-8041 | DOI: | 10.1093/annonc/mdw196 | ISI #: | 000383182800046 | Rights: | © The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2017 |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 1-s2.0-S0923753419347349-main.pdf Restricted Access | Published version | 52.6 kB | Adobe PDF | View/Open Request a copy |
Page view(s)
56
checked on Sep 7, 2022
Download(s)
52
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.